Wortmannin and PD0325901 are inhibitors of PI3K and MEK, respectively, key components in pathways that govern cell proliferation and survival. By blocking these pathways, they can alter the cellular environment, which in turn can modulate the function of proteins involved in these pathways. Further disrupting cellular signaling, SB431542 targets TGF-beta signaling, while Bortezomib interferes with the ubiquitin-proteasome system, crucial for protein turnover and cell cycle control. Y-27632, KN-93 Phosphate, and U73122 intervene in the modulation of cell motility, calcium signaling, and G-protein coupled receptor signaling, respectively. These processes are integral to the maintenance of cellular homeostasis and can have broad effects on the function of regulatory proteins.
Inhibitors like Bisindolylmaleimide and BML-275 act on PKC and AMPK pathways that are involved in various aspects of cell life, including proliferation, differentiation, and metabolism. IWP-2, by inhibiting Wnt production, can affect pathways critical for cell fate decisions. NSC23766 targets the Rac1 pathway, influencing the dynamics of the actin cytoskeleton and cell adhesion, which are vital for cell morphology and intercellular communication. Finally, Omecamtiv mecarbil, though primarily known for its effects on cardiac myosin ATPase, provides an example of how altering motor protein activity can influence cellular functions such as motility.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, which can disrupt cell growth and survival signaling pathways. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits ALK5, which can modulate TGF-beta signaling involved in cellular differentiation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Inhibits the proteasome, affecting protein degradation and cell cycle regulation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits ROCK, which can alter cell motility, apoptosis, and cell cycle progression. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibits CaMKII, and can affect calcium signaling related to numerous cellular functions. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Inhibits PKC, which can affect cell proliferation, differentiation, and apoptosis pathways. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
Inhibits AMPK, which can affect energy homeostasis and metabolic signaling pathways. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
Inhibits Wnt production, affecting Wnt signaling involved in cell fate determination. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Inhibits Rac1, which can modulate actin cytoskeleton dynamics and cell adhesion. | ||||||
Omecamtiv Mecarbil | 873697-71-3 | sc-507399 | 5 mg | $255.00 | ||
Inhibits cardiac myosin ATPase, which can affect muscle contraction and cellular motility. | ||||||